Environmental Obesogens and Human Health by Mahapatra, Archisman et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







Environmental Obesogens and 
Human Health
Archisman Mahapatra, Priya Gupta, Anjali Suman  
and Rahul Kumar Singh
Abstract
Obesity is an alarming public health concern that contributes to a substantially 
increased risk of multiple chronic disorders, including diabetes. As per WHO data, 
in 2016, almost 39% adult population of the world is overweight, 13% of them 
were obese. There is prominent evidence on the involvement of environmental 
endocrine-disrupting chemicals, termed obesogens, in the prevalence of this 
growing worldwide pandemic, obesity. The exaggerated effect of obesogens on 
endocrine disruption, lipid metabolism and homeostasis, adipocyte functioning, 
impaired thermogenesis, inflammation, epigenetics, and overall human health will 
be covered in this chapter. This chapter will discuss the environmental obesogen 
hypothesis, the epidemiological and experimental evidence of obesogens, its 
chemical characteristics, and possible mechanism of actions. It will also focus on 
some recent indications of obesogens and their correlation in COVID-19 disease 
pathogenesis. This chapter will try to conclude with strategies for identifying the 
underlying mechanisms of obesogens within model systems and the human body, 
including future directions.
Keywords: endocrine disrupting chemicals, obesogens, obesity, gut microbiota, 
peroxisome proliferator-activated receptor γ, lipid metabolism, energy homeostasis
1. Endocrine-disrupting chemicals
As defined by the US Environmental Protection Agency (EPA) [1], an 
endocrine-disrupting chemical (EDCs) is “an exogenous agent that interferes with 
synthesis, secretion, transport, metabolism, binding action, or elimination of 
natural blood-borne hormones that are present in the body and are responsible for 
homeostasis, reproduction, and developmental process.” [2] among thousands of 
human-made chemicals, almost 1000 chemicals may have endocrine-disrupting 
properties [3]. Initially, it was thought that EDCs deploy their actions mainly 
through various nuclear hormone receptors like estrogen receptors (ERs), proges-
terone receptors (PRs), androgen receptors (ARs) and thyroid receptors. However, 
as research progressed on EDCs and their mechanism of actions, it is now known 
that they can also act on non-nuclear receptors, nonsteroid receptors, orphan 




As the compounds classified under EDCs are from dispersed heterogeneous 
sources, they can be divided into two major classes, synthetic and natural. Synthetic 
EDCs include industrial solvents and their byproducts [dioxins, polychlorinated 
biphenyls (PCBs), polybrominated biphenyls (PBBs), alkylphenols etc.], agricul-
tural pesticides [methoxychlor (MTX), chlorpyrifos, dichlorodiphenyltrichloroeth-
ane (DDT)], fungicides, herbicides, insecticides, plasticizers [phthalates, bisphenol 
A (BPA)] and pharmaceuticals [diethylstilbestrol (DES)] whereas, phytoestrogens 
(genistein, coumestrol etc.) are grouped under natural sources of EDCs. Humans 
are exposed to the broad range of EDCs mainly through the dietary intake (fish, 
meat, dairy and poultry products) and to some extent by inhalation and dermal 
uptake [2, 4]. Mostly EDCs are highly lipophilic, and they tend to get accumulated 
in the adipose tissues [5, 6]. They can accumulate in human and other large mam-
mals’ fatty tissues through biomagnification and bioaccumulation as they are the 
top predators in the food chain [7]. Due to their long half-life, they remain stored 
in the adipose tissues for years. Persistent Organic Pollutants (POPs) are the best 
example of long term accumulations in human tissues [8]. However, plasticizers like 
BPA have a very short estimated half-life of about four hours. Instead of bioac-
cumulation, they generally get excreted via urine [9]. Still, BPA has a very adverse 
effect on the human endocrine system due to their continuous exposure throughout 
the days [10].
Among the vast range of chemicals under EDCs, some are referred to as 
“obesogens” as they promote or induce weight gain in individuals by altering 
endocrine pathways involved in metabolism, energy homeostasis and appetite. 
The phthalates, perfluorinated compounds, BPA, dioxins, and some pesticides 
showed obesogenic potentials [11, 12]. Though their mechanism of action is 
not very well understood, some report indicated that these chemicals might act 
through Peroxisome proliferator-activated receptor gamma γ (PPAR-γ), a ligand-
activated transcription factor, has a role in various cellular functions as well as 
glucose homeostasis, lipid metabolism, and prevention of oxidative stress [13, 14]. 
Some suggest they may act via the thyroid axis, as the thyroid hormone is a crucial 
regulator of metabolism [15, 16]. Hence, this field is relatively new and emerging in 
EDC’s research and needs further studies.
2. Environmental obesogen hypothesis
The prevalence of obesity and associated diseases like type 2 diabetes, cardiovas-
cular diseases, metabolic syndromes and cancers are progressively increasing at an 
alarming rate in recent years. Globally the cases of obesity have nearly tripled since 
1975. As per a WHO report, in 2016, 13% of adults aged 18 or more are obese world-
wide. A more recent report stated that approximately thirty-eight million children 
(under five years) are obese. In simple language, obesity can be defined as an 
“abnormal or excessive fat accumulation that may impair health” [17]. The measure 
of obesity is generally done by body mass index (BMI), defined as a person’s weight 
in kilograms divided by the square of his/her height in meters (kg/m2). A BMI of 
30 or greater falls within the obese range; the limit changes to 25 or more in Asian 
populations [18, 19]. It is a widely accepted fact that the primary cause of obesity 
is the imbalance between calory intake and energy expenditure. However, obesity 
is a complex disease caused mainly by endocrine disruption, which also involves 
interaction between genetic and environmental factors.
The Obesogen Hypothesis suggests that environmental chemicals, character-
ized as “obesogens,” induce obesity by enhancing the engagement, differentiation 
and size of adipocytes, by altering metabolic setpoints or modifying the hormonal 
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control of appetite and satiety [20]. Many EDCs are obesogens in nature and found 
abundantly in our environment, which may induce adipogenesis and lipid accumu-
lation in the tissues. About 50 of such compounds have been identified to date [20]. 
Various mechanisms of action of the obesogens are discussed later in this chapter.
3. Chemical characteristics of obesogens
Obesogens have peculiar characteristics which make them potential to interfere 
with various endocrine and metabolic pathways. They are believed to be xenohor-
mones as they imitate or partially resemble natural hormones and have unwanted 
physiological effects. They can bind to endocrine receptors present on the cell 
membrane, cytosol, or nucleus, thereby altering their natural functions [21]. Along 
with the structural similarities with native hormones, their ability to do this also 
relies on its lipophilicity and small molecular weight. Partition coefficient, half-life 
and molecular weight are the three main components of xenohormones. A partition 
coefficient (P) is “the ratio of the concentration of a substance in one medium or 
phase (C1) to the concentration in a second phase (C2) when the two concentra-
tions are at equilibrium; that is, partition coefficient = (C1/C2)equal.” [22]. This is 
how the distribution efficiency of a chemical is measured between two mediums. 
Here in obesogen’s case, it is between the tissue and blood. A compound’s octanol–
water partition coefficient expresses that (KOW), referred to the ratio of a chemical’s 
concentration in the octanol phase to its concentration in the aqueous phase of a 
two-phase octanol/water system [23]. It is an essential measure of its lipophilicity 
of a chemical. The bioaccumulation and toxicity of a chemical largely depend upon 
Source Obesogens Chemical characteristics
Log KOW Biological 
Half-life
Mol. weight
Industrial BPA 3.32 21.3 +/− 7.4 h [26] 228.29 g/mol
Bisphenol S (BPS) 1.65 6.8 ± 0.7 h [27] 250.27 g/mol
BDE-47 6.76 [28] 664 days [29] 485.79 g/mol
3,3′,4,4′-Tetrachlorobiphenyl 
(PCB-77)
6.72 1.2 Months [30] 292 g/mol
bis(2-ethylhexyl) phthalate 
(DEHP)
7.6 12 hours [31] 390.6 g/mol
Dioxin 6.8 5.8 years [32] 322 g/mol





6.91 7 years [33] 354.5 g/mol
Tributyltin (TBT) 3.1–4.1 
[34]
23–30 days [35] 290.1 g/mol
Atrazine 2.61 10.8–11.2 hours 
[36]
215.68 g/mol
Pharmaceuticals Diethylstilbestrol (DES) 5.07 2–3 days [37] 268.3 g/mol
Nicotine 1.17 2 h [38] 162.23 g/mol
Note: All values are acquired from the PubChem database otherwise mentioned.
Table 1. 
Chemical characteristics of some obesogens.
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KOW. As being organic, obesogens are naturally lipophilic compound, which means 
they have a higher KOW value. More the value of the KOW of a compound, the more 
will be its tendency to accumulate in the adipose tissues [24].
Now, coming to the half-life, the biological half-life of a chemical is the time it 
takes to break down or eliminate half of the chemical’s quantity from the body. In 
the body, a longer biological half-life implies longer endurance. Ideally, obesogens 
have longer biological half-lives means a short exposure can have life-long conse-
quences [25]. The last of the three properties, molecular weight, refers to the size of a 
compound molecule. Small molecules can diffuse more readily through adipocytes. 
However, many large molecules having high molecular weight can give rise to smaller 
metabolites which may have a similar effect to obesogens [24]. The bioaccumulation 
and the binding affinity for the receptors largely depend upon these three criteria. 
Many obesogens perfectly fit into these criteria. Moreover, some of them are also 
resistant to degradation [e.g. 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47)] [21]. A 
summary of some well-known obesogens with their characteristics is listed in Table 1.
4. Mechanisms of action of obesogens
Though the mechanism of obesogens’ actions in inducing obesity is not very 
clear, some studies suggest few mechanisms by which obesogen could act. This 
disruption of lipid homeostasis by obesogen may involve several mechanisms, some 
of which are as follows (Figure 1):
Figure 1. 
Mechanisms of obesogen actions.
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1. increasing the adipocytes number,
2. increasing the size of the adipocytes,
3. altering endocrine regulation of adipose tissue development,
4. changing hypothalamic regulation of appetite and satiety
5. altering basal metabolic rate and energy homeostasis
6. altering insulin sensitivity at the organ level
4.1 PPARγ-RXR mediated
Obesogens generally disturb the endocrine system by interfering with PPARγ 
and other hormone receptors like estrogen receptor, androgen receptors and 
glucocorticoid receptors. PPARγ is one of the primary regulators of adipogenesis. 
It is highly expressed in adipose tissues and induce differentiation of adipocytes 
by promoting lipogenic enzymes. Along with adipogenesis, it activates genes 
involved in maintaining energy balance. Upon activation, PPARγ forms a het-
erodimer complex with nuclear receptor 9-cis retinoic acid receptor (RXR) an 
act as promoters for the genes required for storage of fatty acid and repression of 
lipolysis. That is why this PPARγ:RXR heterodimer is called the “master regulator 
of adipogenesis” [39]. Obesogen tributyltin (TBT) acts as a ligand and show high 
binding affinity with PPARγ and nuclear receptor RXR. By activating PPARγ and 
RXR, it might promote adipogenesis and lipid dysbiosis [40, 41]. Obesogens like 
spirodiclofen and quinoxyfen activate PPARγ while others like fludioxonil acti-
vate RXR [13]. Phthalates are also known activators of PPARγ, as they are shown 
to promote 3 T3-L1 cells to adipocytes differentiation [42]. Obesogen can increase 
the amount of adipose tissue by increasing the size as well as numbers of adipo-
cytes. They can induce the Mesenchymal Stem Cells (MSCs) to differentiate into 
preadipocytes and adipocytes [43]. In vitro assays show numerous compounds 
with obesogenic properties can induce the Mesenchymal Stem Cells (MSCs) to 
differentiate into preadipocytes and adipocytes via PPARγ dependent pathways. 
TBT exposure to 3 T3-L1 preadipocytes induces them to differentiate into white 
adipose tissues (WAT) [44]. Bisphenol A (BPA), combined with insulin, can 
accelerate the conversion of 3 T3-L1 fibroblasts to adipocytes [45]. Even prenatal 
exposure to TBT in mouse shows preferential differentiation of MSCs towards the 
adipose lineage [43] (Figure 2).
From the studies available so far, it is evident that any ligand which can bind to 
PPARγ can induce adipogenesis and can be called obesogens. However, as human 
adipose tissue stores many of them, they can have a more significant cumulative 
effect. These additive effects are not well studied yet.
4.2 Other receptor-mediated
Obesogens are reported to act via other hormone receptors like estrogen recep-
tor, androgen receptors and glucocorticoid receptors. Many studies have reported 
that they act via the nuclear hormone receptor-mediated pathways. Molecular cross 
talks with other signaling pathways have also been reported. Steroid hormones have 
an essential role in lipid storage and disposition of body fat. Estrogen based hor-
mone replacement therapy is prescribed to women at their menopause to remodel 
their adipose depot. Foetal or neonatal exposure to phytoestrogens may induce 
Endocrine Disruptors
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obesity in later stages of life. Well-known phytoestrogen genistein, commonly 
found in soy-based foods, affects adipose tissue deposition in a dose-dependent and 
gender-specific manner [46].
Neonatal exposure of DES to female mice led to weight gain in adulthood. 
However, this effect can be sex-biased. While some EDCs may act directly via cellular 
steroid receptors by inducing estrogen synthesis, other EDCs may act indirectly. It is 
established that adipose tissue is a site of estrogen synthesis. The adipocyte cytoplasm 
contains the enzyme cytochrome P450 aromatase, which plays a vital role in convert-
ing estrogen from androgen. It is now reported that several EDCs can impair intracel-
lular aromatase activity [47]. This action may raise intracellular estrogen levels in 
adipocytes and lead to obesity irrespective of the sexes [48]. It is reported that TBT 
can directly reduce the activity of the aromatase enzyme in adipose tissue at high 
doses, leading to reduced estradiol levels and down-regulation of the ER target genes. 
TBT also has an inhibitory effect on 11β-hydroxysteroid dehydrogenase 2, which leads 
to reduced inactivation of cortisol. It is believed that increased glucocorticoid levels 
could influence adipocyte differentiation and regulation of metabolism [40].
Some obesogens, especially the persistent organic pollutants (POPs), act via 
the ligand-activated transcription factor aryl hydrocarbon receptor (AhR). AhR 
activates xenobiotic-metabolizing enzyme cytochrome P450s. They can promote 
adipogenesis indirectly by changing PPARγ expression.
4.3 Other mechanisms
In some recent studies, researchers found that they are not linked to activation 
of any nuclear hormone receptors; instead, they followed some novel mechanisms, 
which make their mechanism of action more complex. Those include epigenetic 
modifications, impairment of thermogenesis and dysbiosis in gut microbiota. 
Some of these mechanisms will be discussed in the following sections. Some recent 
Figure 2. 
PPARγ-RXR mediated action of obesogens.
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studies correlated COVID-19 pandemic to the obesogenic exposures, that is also 
being discussed in this chapter.
4.3.1 Epigenetic modifications
Epigenetics is defined as the study of heritable changes in phenotype resulting 
from environmentally influenced modifications of genome. Epigenetic modifica-
tion can alter gene expression during development and cellular differentiation in 
response to environmental factors such as chemical contaminants. These modifica-
tions include DNA methylation at cytosine residues of 5′ to guanine sites (CpG 
sites), chemically modifying histone proteins and noncoding RNAs interference 
[49]. DNA methylation was considered a key mechanism responsible for adult 
diseases with developmental origins [50]. DNA methylation changes are responsible 
for the transgenerational effects of exogenous exposed individuals to chemicals and 
nutrition deficits [51]. For instance, the obesogen pesticide TBT induced changes 
in DNA methylation and histone modification invitro. Various reports have docu-
mented the environmental chemicals, including obesogens, led to an epigenetic 
modification in vivo and obesogen phenotype even in unexposed generations. TBT 
exposure in 3 T3-L1 mice preadipocytes invitro resulted in increased adipocyte dif-
ferentiation along with decreased DNA methylation levels. Increased differentiation 
level towards the adipogenic lineage was observed in adipose-derived stromal cells 
(ADSCs) isolated from TBT exposed mice perinatally but at the cost of decreased 
osteogenesis. ADSCs exposed to TBT were associated with increased adipogenesis 
marker genes, such as PPARγ target gene Fapb4, where methylation level decreased 
in the promoter region. However, PPARγ mRNA levels were increased, but DNA 
methylation at its promoter region had no effects [43]. A possible reason for this 
lack of epigenetic regulation might be that EDC exposure during differentiation 
process causes DNA histone demethylation. Ultimately, PPARγ, which is under the 
control of H3K27me3, causes the gene to be promptly up-regulated. Importantly, 
prenatal exposure to TBT has been recently shown to cause the transgenerational 
inheritance of adiposity. It remains to be determined whether these transgenera-
tional effects are related to permanent changes in DNA methylation profiles or 
other epigenetic processes.
4.3.2 Impairment of thermogenesis
Recent advances found in understanding adipocyte function was the presence 
of thermogenic brown adipose tissue (BAT) in adult human beings in a dispersed 
manner, not as found in concentrated discrete depots in human infants. Another 
discovery of white adipose tissue can also be induced to produce thermogenic fat 
called beige or brite fat. Increased mitochondria production is responsible for 
differentiation of both bona fide brown adipocytes and beiging of white adipocytes. 
This thermogenesis relies on the capacity to dissipate energy in the form of heat 
through uncoupling of cellular oxidative phosphorylation and ATP synthesis via 
Uncoupling protein 1 (UCP1) or sometimes through shivering. Some of the evi-
dence has documented how some obesogens impede the production and function 
of thermogenic adipocytes. For instance, perinatal exposures to DDT in mice have 
long term-effects on thermogenesis regulation in their female offspring. When 
female offspring reached up to 6 months of age, they showed reduced energy 
expenditure & ultimately decreased thermogenesis capacity. However, no change 
in their physical activity was observed. Thermogenesis impairment was due to the 
decreased expression of PPAR-γ co-activator 1α (Ppargc1a), a master regulator 
Endocrine Disruptors
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for thermogenesis related genes and type 2 iodothyronine deiodinase (DiO2) (the 
enzyme that catalyzes thyroid hormone T4 to convert into T3 which stimulates BAT 
thermogenesis) [52]. Secondly, Shoucri and his colleagues [49] found that TBT or 
rexinoids have inhibited adipocytes’ production. Other EDCs increase thermogen-
esis by changing mRNA and protein levels of UCP-1. Adult mice exposed to PFOA 
and PFOS through diet (containing 0.02% w/w) for ten days exhibited BAT mito-
chondria activation for increased oxidative capacity and protein levels of UCP-1, 
resulting in decreased depots size of adipose tissue. PFOA exposure (80–40 μM) 
during in-vitro experiments activates UCP1 similarly as fatty acids. These examples 
indicate how obesogens influence obesity by impairing thermogenesis during the 
in-vitro and in vivo study. This intriguing area of obesogen epidemic and their 
mechanism remains to be elucidated. Through their Horizon 2020 programme, the 
European Union has funded several grants to establish new assays to assess EDCs 
effects on metabolic-end points and identify those chemicals that affect thermogen-
esis [53].
4.3.3 Gut microbiota dysbiosis
The gut microbiome is defined as “the totality of microorganisms, bacteria, 
viruses, protozoa, and fungi, and their collective genetic material present in the 
gastrointestinal tract” by molecular biologist Joshua Lederberg. Obesogen exposure 
could lead to obesity by altering the gut microbiome, a relatively novel mechanism 
which leads to obesity. It is well understood that obesity is correlated with gut 
microbiome composition [54]. Some experimental data shows that the transplant 
of gut microbe from obese mice can induce obesity in lean mice [55]. Conversely, 
the gut microbiome transplant from lean donors improved the metabolic disorder 
condition in obese mice [56]. It is evident from several experimental data that 
many obesogens induce the gut microbiome dysbiosis in zebrafish [57], mice [58] 
and human [59]. In mice, gut microbial dysbiosis was associated with increased fat 
accumulation or impaired lipid metabolism after exposure to triphenyl phosphate. 
Tributyltin exposure induces gut microbiome dysbiosis with increased body weight 
gain and dyslipidemia in mice [58]. Though, it is not yet apparent whether this 
metabolic disruption is a result of the gut microbiota dysbiosis or not.
Additionally, some microbial metabolites have also been reported as AhR ago-
nists and antagonists [60, 61], as we are already aware that activating AhR inhibits 
adipogenesis. In contrast, inhibition of the activity leads to obesity and fatty liver 
disease. Two basic dietary emulsifiers, carboxymethylcellulose and P-80, were 
reported to initiate intestinal inflammation and gut microbiota dysbiosis, which 
led to metabolic disorder and increased body weight in mice [62]. These pieces of 
evidence suggest that inducing obesity via gut microbiota dysbiosis is possibly a 
potent mechanism for the obesogens to follow. However, to get more clues, this field 
needs to be studied further extensively.
4.3.4 Obesogens and COVID-19
The current outbreak of novel coronavirus has emerged as a worldwide pan-
demic in the past year, which is related to the Severe Acute Respiratory Syndrome 
Coronavirus (SARS-CoV) in 2003 and the Middle East Respiratory Syndrome 
Coronavirus (MERS-CoV) in 2012 [63]. Interestingly, a study in 2003 found 
a positive correlation between air pollution and extreme SARS in the Chinese 
population. Patients with SARS from regions with a high air pollution index 
(API) were twice as likely as those from regions with low APIs to die from SARS 
[64]. A finding based on US population found that long-term exposure to air 
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pollution resulted in a 6% rise in cardiopulmonary mortality risk. Some of these 
pollutants are potent obesogenic [65].
Human studies have even shown nitrogen dioxide (NO2), one of the compo-
nents of air pollution, is correlated with higher fasting serum lipids among obese 
individuals, indicating that obesity can worsen the effects of air pollution [66]. 
Animal studies have also shown that air pollution particles’ sensitivity early in life 
will contribute to increased visceral obesity, insulin tolerance, and inflammation, 
signaling NO2’s function as an endocrine disruptor [67]. Since COVID-19 is similar 
to SARS in causing respiratory disease, exposure to NO2 can increase the mortality 
rate of patients with COVID-19. However, future studies are needed to validate this 
relationship.
5. Transgenerational effects
One of the most intriguing results in EDCs field came when a series of reports were 
published by Skinner and colleagues showing EDCs, including DDT and MTX, induce 
transgenerational obesogenic effects. During F1 generation, prenatally exposed 
individuals with anti-androgenic fungicide vinclozolin or estrogenic pesticide MTX 
were associated with disease in various organs in their F4 generation [68]. Similarly, 
when pregnant mice (FO generation) were exposed to environmentally relevant doses 
(nM) of TBT through drinking water, then effects on obesity were observed in F1-F3 
descendants of exposed animals [69]. Notably, in a similar experiment, the pharma-
cological obesogen, Rosiglitazone, which can activate PPARγ, could not produce the 
same transgenerational obesity effects suggesting that different pathways in addition 
to PPARγ were required to generate transgenerational phenotype [69].
In addition to TBT effects on obesity, Skinner lab has shown several environ-
mental chemicals such as plasticizer (BPA, DEHP, DBP) [70], pesticides MTX [71], 
a mixed hydrocarbon mixture (jet fuel JP-8) [72] and the widely used pesticide 
DDT [73], induced transgenerational obesity in a rat model as observed in F3/
F4 offspring of ancestral prenatal or perinatal obesogen exposed-FO individuals 
[71–73]. Although molecular mechanisms underlying transgenerational inheritance 
of obesity are currently controversial, researchers belonging to the EDC field 
believe that these obesogen effects are inherited in an epigenetic manner. This point 
has got stronger resistance in the genetics sphere [74].
6. Epidemiological evidence of obesogens
6.1 Human cohort studies
Epidemiological studies are of considerable significance for the association of 
disease effects with exposure to obesogens. Few cohort-based studies are avail-
able to date on the effect of obesogens in human populations. Since a considerable 
amount of evidence indicate that prenatal exposures predispose patients to obesity, 
epidemiological research concentrates on obesogenic measurements throughout 
pregnancy. Increase in child adiposity in multiple birth cohorts was associated with 
prenatal exposure to PFAS. At the same time, sexual dimorphism was sometimes 
linked with it [75–79]. A metapopulation analysis, including ten cohorts, suggests 
a 25% and 0.1 unit increase in weight and BMI, respectively, per ng/ml of PFOA 
concentration in maternal blood [80].
A research found that rising concentrations of maternal urinary phthalate 
during gestation doubled the risk of the offspring becoming overweight or obese 
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[81]. Cohort research on the impact of prenatal BPA exposure has also been cor-
related with increased waist circumference, BMI, and risk of obesity [82]. Studies 
of prenatal exposure to phthalates and bisphenols have not shown a consistent 
association with measures of childhood adiposity compared to studies of prenatal 
exposure to PFAS [83]. Two studies on the American population showed an associa-
tion between serum concentrations of PFAS and weight gain irrespective of sexes 
[84]. PFAS, particularly perfluorooctane sulfonate (PFOS) and perfluorononanoic 
acid (PFNA), were linked with alteration in metabolic rate [85].
Few studies have explored the longitudinal impacts on postnatal growth of pre-
natal exposure to other chemicals. Evidence risen over the past five years indicates 
that exposure to phthalates leads to adult weight gain, with most research con-
ducted in women. Some studies by the Women’s Health initiative reported a strong 
correlation between urine concentrations of phthalate metabolites and weight gain 
[86]. Again, it is to be considered that the effect of a single chemical mostly reflects 
the epidemiological studies conducted. However, naturally, obesogens ploy cumu-
lative effect as mixtures. The WAT is the depot of obesogens in the human body. 
More studies should be designed to estimate the accumulative effect of mixtures 
in future.
6.2 In vitro models
In vitro models have several advantages over other model systems. Taking 
human cells lines for the study can be of great significance considering the physi-
ological relevance. For screening new chemicals for potential obesogenic properties, 
in vitro studies are generally conducted before animal models. Several cell lines are 
used to study the obesogenic impacts of several compounds. Among the in vitro 
models, mouse embryo pre adipocyte 3 T3-L1 has been used extensively to check 
the effects of obesogens like TBT [87], BPA [88], BPS [89], genistein [90], phthal-
ate [91], nonylphenol [92] and so on. Other cell lines include C2C12 (mice muscle 
cells) [93], HELA (human cervical cancer cells) [93], HEK293C (human embryonic 
kidney cells) [94], HepG2 (human liver carcinoma cells) [95], hASCs (human 
adipose-derived stem cells) [96], C57BL/6 (mice bone marrow stromal cells) [97], 
hESCs (human embryonic-derived stem cells) [98] etc.
6.3 In vivo models
Though animal models are not recommended to study certain chemicals’ obe-
sogenic potential, they do not mimic the human physiological systems. Still, in vivo 
model systems have certain advantages over in vitro systems as whole-body kinetics 
and systemic effects can be studied using animal models. Complex linked pathways 
involving multiple organs, including adipose tissue, liver, pancreas, muscle, brain, 
etc., regulate metabolism and weight. In understanding the role of chronic inflam-
mation and hormone interference, in vivo experiment is particularly relevant. The 
most widely used animal model for the study of obesogens is rodents. Multiple 
obesogens including TBT [69], BPA [99], triphenyltin [100], DEHP [101], DES 
[102], polycyclic aromatic hydrocarbons, DDT, and nicotine, have been defined 
as murine models. Mice are identical biologically and anatomically to humans and 
share many common diseases. It is incredibly useful for diseases with an inflamma-
tory condition, such as obesity, as animal models can mimic complex inflammatory 
responses. A transgenic model like obese or lean bodied mice can also be created 
by manipulating required genes. Other commonly used in vivo models include rats 
[103], zebrafish [104] and drosophila [105]. Many insights into possible obesogens 
and various modes of action were provided using in vivo models to investigate 
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endocrine disruption. They may not replicate human physiology, as discussed 
earlier. Mice exposed to a specified amount of one particular molecule over weeks 
sometimes does not reflect a chronic variable exposure in humans to multiple 
chemicals over the years. In detecting obesogens and discerning mechanisms of 
action, animal models play an essential role. However, they should be combined 
to draw the most reliable conclusions with knowledge from in vitro studies and 
epidemiological studies.
7. Strategies for change and future directions
The obesity epidemic first continues in the US and afterwards expands 
worldwide; therefore, it becomes a dire need to understand the predisposition 
and related disorders’ mechanisms. It becomes of utmost importance to study 
the extent to which the obesogen exposure influences obesity in humans and 
establishes the risk factors related to obesity. The risk factors include oxidative 
stress, inflammation, disrupted circadian rhythms, mitochondrial dysfunction and 
dietary composition. These interactions may be critical in the effects of obesogen 
exposure. Evidence documented in the obesogen research area shows that their 
effect mainly depends on the level and timing of exposure, especially critical 
windows of exposure during fetal development. Hence, it is crucial to reduce or 
avoid exposure to obesogens, specifically during pregnancy. However, there is 
no technique to determine if the individuals have been exposed to any obesogens 
during their development. It will be a “Holy grail” to identify biomarkers of 
exposure in obesogen research and establish links among obesogen exposure and 
other factors related to obesity. The obesogen hypothesis opened a new field into 
obesity by linking EDCs research with developmental disease origin. The obesogen 
hypothesis is still in the dearth of research. It requires more studies in the mecha-
nism, developmental time windows and diet interaction. The effects of obesogens 
are related to epigenetics.
However, we still need more research to understand the mechanism and how 
the effects get transmitted to forthcoming generations. For instance, how does the 
obesogen exposure of pregnant Fo female mice lead to obesity in upcoming F3 and 
F4 unexposed males? There is an extreme lack of data on how obesogen exposure 
programs adipose tissue dysfunctional that could readily store but not mobilize 
fat. The obesogen sphere is almost 15 years old only. Much has been studied 
related to potential effects of EDCs and obesogens. The most substantial evidence 
for chemical obesogens existence may be the variety of pharmaceuticals that 
have the side effects of making patients obese. Several international and national 
workshops have been held to understand the potential role of EDCs in obesity 
and related metabolic disorders [53]. Thus, various policies and strategies should 
investigate the magnitude of environmental obesogenic pollutants on the obesity 
epidemic and the regulatory actions required on such chemicals to improve 
public health.
8. Conclusion
The majority of evidence that indicates the role of EDCs in driving obesity 
provides a mechanistic explanation of the obesity epidemic and a management 
strategy. The role of exogenous chemicals in growing rates of obesity through gene 
expression regulation (such as PPARs), hormone changes, and inflammation is 
supported by ample evidence. While overeating, combined with lack of exercise, 
Endocrine Disruptors
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is undoubtedly a significant contributor to the increase in obesity that can be 
addressed by decreased calorie intake and increased exercise, it may be that reduc-
ing exposure to obesogenic EDCs may also contribute to reducing obesity in the 
population, especially during the early stages of life. More knowledge of obesogenic 
pathways will improve prophylactic and therapeutic strategies. The extensive 
exposure of the human population to so many EDCs with obesogenic action needs 
evaluation. In vitro models are useful screening devices for detecting and testing 
obesogenic mechanisms, notably, changes in gene expression or molecular path-
ways. Improvements to these models will improve human extrapolation in vitro 
to in vivo as well. However, animal models remain a valuable and typically physi-
ologically precise method for studying obesogenic inter-organ pathways, including 
hormone interference and inflammation. More epidemiological studies should 
be made to confirm in vitro and in vivo animal models and provide unparalleled 
insight into human obesogen exposures and effects. Integrating the data collected 
from all three of these model systems would result in better-informed choices of 
compounds that can be used to replace obesogens in food production, packaging, 
etc. It will, essentially, reduce the economic burden of obesity.
Acknowledgements
All authors thank Banaras Hindu University, India, for providing necessary 
resources and support to write the present chapter with the support from University 
Grant Commission (UGC)-Junior Research Fellowship to AM, PG and AS. This 
work received no external funding from any agency.
Conflict of interest
The author declares that there is no conflict of interest.
Author contributions
All authors listed have made a substantial contribution to this chapter. 
Moreover, special thanks to PG for writing some sections and proofreading the 
whole manuscript. Thanks to RKS for reviewing the manuscript before the final 
submission.
13
Environmental Obesogens and Human Health
DOI: http://dx.doi.org/10.5772/intechopen.96730
Author details
Archisman Mahapatra, Priya Gupta, Anjali Suman and Rahul Kumar Singh*
Department of Zoology, Molecular Endocrinology and Toxicology Lab (METLab), 
Institute of Science, Banaras Hindu University, Varanasi, India
*Address all correspondence to: rks.rna@gmail.com
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 




[1] EPA, (n.d.). https://www.epa.gov/.
[2] E. Diamanti-Kandarakis, J.-P. 
Bourguignon, L.C. Giudice, R. Hauser, 
G.S. Prins, A.M. Soto, R.T. Zoeller, A.C. 
Gore, Endocrine-disrupting chemicals: an 
Endocrine Society scientific statement., 
Endocr. Rev. 30 (2009) 293-342. https://
doi.org/10.1210/er.2009-0002.
[3] P. Andrea C. Gore, P. David Crews, P. 
Loretta L. Doan, M. Michele La Merrill, 
PhD, P. Heather Patisaul, M. Ami Zota, 
ScD, INTRODUCTION TO ENDOCRINE 
DISRUPTING CHEMICALS (EDCs) 
A GUIDE FOR PUBLIC INTEREST 
ORGANIZATIONS AND POLICY-
MAKERS, Endocr. Soc. (2014).
[4] A.C. Gore, V.A. Chappell, S.E. 
Fenton, J.A. Flaws, A. Nadal, G.S. Prins, 
J. Toppari, R.T. Zoeller, EDC-2: The 
Endocrine Society’s Second Scientific 
Statement on Endocrine-Disrupting 
Chemicals., Endocr. Rev. 36 (2015) 
E1–E150. https://doi.org/10.1210/
er.2015-1010.
[5] J.J. Heindel, R. Newbold, T.T. Schug, 
Endocrine disruptors and obesity., Nat. 
Rev. Endocrinol. 11 (2015) 653-661. 
https://doi.org/10.1038/nrendo.2015.163.
[6] R.M. Sargis, Metabolic disruption in 
context: Clinical avenues for synergistic 
perturbations in energy homeostasis 
by endocrine disrupting chemicals., 
Endocr. Disruptors (Austin, Tex.). 3 
(2015) e1080788. https://doi.org/10.108
0/23273747.2015.1080788.
[7] P. Balaguer, V. Delfosse, M. Grimaldi, 
W. Bourguet, Structural and functional 
evidences for the interactions between 
nuclear hormone receptors and endocrine 
disruptors at low doses, Comptes Rendus 
- Biol. 340 (2017) 414-420. https://doi.
org/10.1016/j.crvi.2017.08.002.
[8] P.D. Darbre, Endocrine Disruptors 
and Obesity., Curr. Obes. Rep. 6 
(2017) 18-27. https://doi.org/10.1007/
s13679-017-0240-4.
[9] R.W. Stahlhut, W. V Welshons, S.H. 
Swan, Bisphenol A data in NHANES 
suggest longer than expected half-life, 
substantial nonfood exposure, or both., 
Environ. Health Perspect. 117 (2009) 
784-789. https://doi.org/10.1289/
ehp.0800376.
[10] A.M. Calafat, X. Ye, L.-Y. Wong, 
J.A. Reidy, L.L. Needham, Exposure of 
the US population to bisphenol A and 
4-tertiary-octylphenol: 2003-2004., 
Environ. Health Perspect. 116 (2008) 
39-44. https://doi.org/10.1289/ehp.10753.
[11] C. Casals-Casas, B. Desvergne, 
Endocrine disruptors: from 
endocrine to metabolic disruption., 
Annu. Rev. Physiol. 73 (2011) 
135-162. https://doi.org/10.1146/
annurev-physiol-012110-142200.
[12] F. Grün, B. Blumberg, Perturbed 
nuclear receptor signaling by 
environmental obesogens as emerging 
factors in the obesity crisis., Rev. Endocr. 
Metab. Disord. 8 (2007) 161-171. https://
doi.org/10.1007/s11154-007-9049-x.
[13] A. Janesick, B. Blumberg, 
Minireview: PPARγ as the target of 
obesogens., J. Steroid Biochem. Mol. 
Biol. 127 (2011) 4-8. https://doi.
org/10.1016/j.jsbmb.2011.01.005.
[14] M. Chandra, S. Miriyala, M. 
Panchatcharam, PPARγ and Its Role 
in Cardiovascular Diseases., PPAR 
Res. 2017 (2017) 6404638. https://doi.
org/10.1155/2017/6404638.
[15] R.T. Zoeller, Environmental 
chemicals impacting the thyroid: 
targets and consequences., Thyroid. 17 
(2007) 811-817. https://doi.org/10.1089/
thy.2007.0107.
[16] M. Boas, K.M. Main, U. Feldt-
Rasmussen, Environmental chemicals 
15
Environmental Obesogens and Human Health
DOI: http://dx.doi.org/10.5772/intechopen.96730
and thyroid function: an update., Curr. 
Opin. Endocrinol. Diabetes. Obes. 16 
(2009) 385-391. https://doi.org/10.1097/
MED.0b013e3283305af7.
[17] WHO, WHO report, (n.d.). https://
www.who.int/news-room/fact-sheets/
detail/obesity-and-overweight.
[18] CDC, About adult BMI, (2017). 
https://www.cdc.gov/healthyweight/
assessing/bmi/adult_bmi/index.html.
[19] S. Wan Siang Cheong, Gen Re, 
Overweight and Obesity in Asia, 
Underwrit. Focus. (2014).
[20] J.J. Heindel, B. Blumberg, 
Environmental Obesogens: Mechanisms 
and Controversies., Annu. Rev. 
Pharmacol. Toxicol. 59 (2019) 
89-106. https://doi.org/10.1146/
annurev-pharmtox-010818-021304.
[21] L.N. Vandenberg, T. Colborn, 
T.B. Hayes, J.J. Heindel, D.R.J. Jacobs, 
D.-H. Lee, T. Shioda, A.M. Soto, F.S. 
vom Saal, W. V Welshons, R.T. Zoeller, 
J.P. Myers, Hormones and endocrine-
disrupting chemicals: low-dose effects 
and nonmonotonic dose responses., 
Endocr. Rev. 33 (2012) 378-455. https://
doi.org/10.1210/er.2011-1050.
[22] P.M. Schlosser, Inhalation Exposure 
and Absorption of Toxicants, Compr. 
Toxicol. (2010) 75.
[23] H. Cumming, C. Rücker, Octanol-
Water Partition Coefficient Measurement 
by a Simple (1)H NMR Method., ACS 
Omega. 2 (2017) 6244-6249. https://doi.
org/10.1021/acsomega.7b01102.
[24] E. Jackson, R. Shoemaker, N. Larian, 
L. Cassis, Adipose Tissue as a Site of 
Toxin Accumulation, Compr. Physiol. 
(2017) 1085-1135. https://doi.org/https://
doi.org/10.1002/cphy.c160038.
[25] Y.-M. Lee, K.-S. Kim, D.R.J. Jacobs, 
D.-H. Lee, Persistent organic pollutants 
in adipose tissue should be considered in 
obesity research., Obes. Rev. an Off. J. Int. 
Assoc. Study Obes. 18 (2017) 129-139. 
https://doi.org/10.1111/obr.12481.
[26] H. Choudhury, T. Harvey, W.C. 
Thayer, T.F. Lockwood, W.M. Stiteler, 
P.E. Goodrum, J.M. Hassett, G.L. 
Diamond, Urinary cadmium elimination 
as a biomarker of exposure for 
evaluating a cadmium dietary exposure-
-biokinetics model., J. Toxicol. Environ. 
Health. A. 63 (2001) 321-350. https://
doi.org/10.1080/15287390152103643.
[27] J. Oh, J.W. Choi, Y.-A. Ahn, S. 
Kim, Pharmacokinetics of bisphenol 
S in humans after single oral 
administration., Environ. Int. 112 
(2018) 127-133. https://doi.org/10.1016/j.
envint.2017.11.020.
[28] H. Liu, S. Tang, X. Zheng, Y. 
Zhu, Z. Ma, C. Liu, M. Hecker, DM V 
Saunders, J.P. Giesy, X. Zhang, H. Yu, 
Bioaccumulation, biotransformation, 
and toxicity of BDE-47, 6-OH-BDE-47, 
and 6-MeO-BDE-47 in early life-stages 
of zebrafish (Danio rerio)., Environ. Sci. 
Technol. 49 (2015) 1823-1833. https://
doi.org/10.1021/es503833q.
[29] D.F. Staskal, J.J. Diliberto, M.J. 
DeVito, L.S. Birnbaum, Toxicokinetics 
of BDE 47 in female mice: effect of dose, 
route of exposure, and time., Toxicol. 
Sci. 83 (2005) 215-223. https://doi.
org/10.1093/toxsci/kfi018.
[30] M.O. Milbrath, Y. Wenger, C.-W. 
Chang, C. Emond, D. Garabrant, B.W. 
Gillespie, O. Jolliet, Apparent half-lives 
of dioxins, furans, and polychlorinated 
biphenyls as a function of age, body fat, 
smoking status, and breast-feeding., 










[32] L. Magos, W. J. Hayes, Jr. and E. 
R. Laws, Jr. Handbook of pesticide 
toxicology volume 1: General principles; 
Volumes 2 and 3: Classes of pesticides. 
Academic Press, San Diego, 1991. 
1576 pp., $395.00, J. Appl. Toxicol. 12 
(1992) 75-76. https://doi.org/https://doi.
org/10.1002/jat.2550120118.
[33] T. Woodruff, M.S. Wolff, D.L. 
Davis, D. Hayward, Organochlorine 
exposure estimation in the study of 
cancer etiology., Environ. Res. 65 
(1994) 132-144. https://doi.org/10.1006/
enrs.1994.1026.
[34] European Commission, 2005.
[35] International Programme on 
Chemical Safety as accessed on 8 Feb, 
2021, (n.d.). http://www.inchem.org/
documents/pims/chemical/pimg018.htm.
[36] USD of H. And, H. Services, 
PH Service, A. for T. Substances, 
and D. Registry, ToxGuideTM for 
Atrazine, 2003.
[37] C.E. Reed, S.E. Fenton, Exposure 
to diethylstilbestrol during sensitive 
life stages: a legacy of heritable health 
effects., Birth Defects Res. C. Embryo 
Today. 99 (2013) 134-146. https://doi.
org/10.1002/bdrc.21035.
[38] International Programme on 
Chemical Safety as accessed on 8 Feb, 
2021, (n.d.). http://www.inchem.org/
documents/pims/chemical/nicotine.htm.
[39] P. Tontonoz, B.M. Spiegelman, 
Fat and beyond: the diverse biology of 
PPARgamma., Annu. Rev. Biochem. 77 
(2008) 289-312. https://doi.org/10.1146/
annurev.biochem.77.061307.091829.
[40] F. Grün, H. Watanabe, Z. 
Zamanian, L. Maeda, K. Arima, R. 
Cubacha, D.M. Gardiner, J. Kanno, 
T. Iguchi, B. Blumberg, Endocrine-
disrupting organotin compounds are 
potent inducers of adipogenesis in 
vertebrates., Mol. Endocrinol. 20 (2006) 
2141-2155. https://doi.org/10.1210/
me.2005-0367.
[41] A. le Maire, M. Grimaldi, D. 
Roecklin, S. Dagnino, V. Vivat-Hannah, 
P. Balaguer, W. Bourguet, Activation of 
RXR-PPAR heterodimers by organotin 
environmental endocrine disruptors., 
EMBO Rep. 10 (2009) 367-373. https://
doi.org/10.1038/embor.2009.8.
[42] L. Yin, K.S. Yu, K. Lu, X. Yu, Benzyl 
butyl phthalate promotes adipogenesis 
in 3T3-L1 preadipocytes: A High Content 
Cellomics and metabolomic analysis., 
Toxicol. In Vitro. 32 (2016) 297-309. 
https://doi.org/10.1016/j.tiv.2016.01.010.
[43] S. Kirchner, T. Kieu, C. Chow, S. 
Casey, B. Blumberg, Prenatal exposure 
to the environmental obesogen 
tributyltin predisposes multipotent 
stem cells to become adipocytes., Mol. 
Endocrinol. 24 (2010) 526-539. https://
doi.org/10.1210/me.2009-0261.
[44] X. Li, J. Ycaza, B. Blumberg, The 
environmental obesogen tributyltin 
chloride acts via peroxisome proliferator 
activated receptor gamma to induce 
adipogenesis in murine 3T3-L1 
preadipocytes., J. Steroid Biochem. 
Mol. Biol. 127 (2011) 9-15. https://doi.
org/10.1016/j.jsbmb.2011.03.012.
[45] H. Masuno, T. Kidani, K. Sekiya, K. 
Sakayama, T. Shiosaka, H. Yamamoto, K. 
Honda, Bisphenol A in combination with 
insulin can accelerate the conversion of 
3T3-L1 fibroblasts to adipocytes., J. Lipid 
Res. 43 (2002) 676-684.
[46] M. Penza, C. Montani, A. Romani, 
P. Vignolini, B. Pampaloni, A. Tanini, 
M.L. Brandi, P. Alonso-Magdalena, 
A. Nadal, L. Ottobrini, O. Parolini, 
E. Bignotti, S. Calza, A. Maggi, P.G. 
Grigolato, D. Di Lorenzo, Genistein 
affects adipose tissue deposition in a 
dose-dependent and gender-specific 




Environmental Obesogens and Human Health
DOI: http://dx.doi.org/10.5772/intechopen.96730
[47] S.A. Whitehead, S. Rice, Endocrine-
disrupting chemicals as modulators 
of sex steroid synthesis., Best Pract. 
Res. Clin. Endocrinol. Metab. 20 
(2006) 45-61. https://doi.org/10.1016/j.
beem.2005.09.003.
[48] G. Williams, Aromatase 
up-regulation, insulin and raised 
intracellular oestrogens in men, induce 
adiposity, metabolic syndrome and 
prostate disease, via aberrant ER-α and 
GPER signalling., Mol. Cell. Endocrinol. 
351 (2012) 269-278. https://doi.
org/10.1016/j.mce.2011.12.017.
[49] BM. Shoucri, B. Blumberg, Impact 
of Environmental Obesogens, Child. 
Obes. (2016) 219-234. https://doi.
org/10.1201/9781315370958-21.
[50] S. Ho, W. Tang, Techniques used 
in studies of epigenome dysregulation 
due to aberrant DNA methylation: 
an emphasis on fetal-based adult 
diseases., Reprod. Toxicol. 23 (2007) 
267-282. https://doi.org/10.1016/j.
reprotox.2007.01.004.
[51] T.T. Schug, A. Janesick, B. Blumberg, 
J.J. Heindel, Endocrine disrupting 
chemicals and disease susceptibility, J. 
Steroid Biochem. Mol. Biol. 127 (2011) 
204-215. https://doi.org/10.1016/j.
jsbmb.2011.08.007.
[52] A. Nadal, I. Quesada, E. Tudurí, 
R. Nogueiras, P. Alonso-Magdalena, 
Endocrine-disrupting chemicals and the 
regulation of energy balance, Nat. Rev. 
Endocrinol. 13 (2017) 536-546. https://
doi.org/10.1038/nrendo.2017.51.
[53] M.K. Lee, B. Blumberg, Trans-
generational effects of obesogens, Basic 
Clin. Pharmacol. Toxicol. 125 (2019) 
44-57. https://doi.org/https://doi.
org/10.1111/bcpt.13214.
[54] P.J. Turnbaugh, F. Bäckhed, L. 
Fulton, J.I. Gordon, Diet-induced 
obesity is linked to marked but 
reversible alterations in the mouse 
distal gut microbiome., Cell Host 
Microbe. 3 (2008) 213-223. https://doi.
org/10.1016/j.chom.2008.02.015.
[55] P.J. Turnbaugh, R.E. Ley, M.A. 
Mahowald, V. Magrini, E.R. Mardis, 
J.I. Gordon, An obesity-associated gut 
microbiome with increased capacity for 
energy harvest., Nature. 444 (2006) 
1027-1031. https://doi.org/10.1038/
nature05414.
[56] A. Vrieze, E. Van Nood, F. Holleman, 
J. Salojärvi, R.S. Kootte, J.F.W.M. 
Bartelsman, G.M. Dallinga-Thie, M.T. 
Ackermans, M.J. Serlie, R. Oozeer, 
M. Derrien, A. Druesne, J.E.T. Van 
Hylckama Vlieg, V.W. Bloks, A.K. Groen, 
H.G.H.J. Heilig, E.G. Zoetendal, E.S. 
Stroes, W.M. de Vos, J.B.L. Hoekstra, 
M. Nieuwdorp, Transfer of intestinal 
microbiota from lean donors increases 
insulin sensitivity in individuals with 
metabolic syndrome., Gastroenterology. 
143 (2012) 913-6.e7. https://doi.
org/10.1053/j.gastro.2012.06.031.
[57] A.N. Buerger, D.T. Dillon, J. Schmidt, 
T. Yang, J. Zubcevic, C.J. Martyniuk, 
J.H.J. Bisesi, Gastrointestinal dysbiosis 
following diethylhexyl phthalate 
exposure in zebrafish (Danio rerio): 
Altered microbial diversity, functionality, 
and network connectivity., Environ. 
Pollut. 265 (2020) 114496. https://doi.
org/10.1016/j.envpol.2020.114496.
[58] J. Zhan, X. Ma, D. Liu, Y. Liang, 
P. Li, J. Cui, Z. Zhou, P. Wang, Gut 
microbiome alterations induced by 
tributyltin exposure are associated with 
increased body weight, impaired glucose 
and insulin homeostasis and endocrine 
disruption in mice., Environ. Pollut. 266 
(2020) 115276. https://doi.org/10.1016/j.
envpol.2020.115276.
[59] K.-P. Lai, Y.-T. Chung, R. Li, H.-T. 
Wan, C.K.-C. Wong, Bisphenol A 
alters gut microbiome: Comparative 
metagenomics analysis., Environ. 




[60] U.-H. Jin, S.-O. Lee, G. Sridharan, K. 
Lee, L.A. Davidson, A. Jayaraman, R.S. 
Chapkin, R. Alaniz, S. Safe, Microbiome-
derived tryptophan metabolites and their 
aryl hydrocarbon receptor-dependent 
agonist and antagonist activities., Mol. 
Pharmacol. 85 (2014) 777-788. https://
doi.org/10.1124/mol.113.091165.
[61] J. Ji, H. Qu, Cross-regulatory Circuit 
Between AHR and Microbiota., Curr. 
Drug Metab. 20 (2019) 4-8. https://
doi.org/10.2174/1389200219666180
129151150.
[62] B. Chassaing, O. Koren, J.K. 
Goodrich, A.C. Poole, S. Srinivasan, 
R.E. Ley, A.T. Gewirtz, Dietary 
emulsifiers impact the mouse gut 
microbiota promoting colitis and 
metabolic syndrome., Nature. 519 
(2015) 92-96. https://doi.org/10.1038/
nature14232.
[63] A. Mahapatra, P. Gupta, R.K. Singh, 
An Overview of Sars-Cov-2 Features, 
Replication, Pathophysiology and 
Therapeutic Approaches, COVID-19 
Pandemic Updat. 2020. (2020) 29-53. 
https://doi.org/10.26524/royal.37.3.
[64] Y. Cui, Z.-F. Zhang, J. Froines, J. 
Zhao, H. Wang, S.-Z. Yu, R. Detels, 
Air pollution and case fatality of 
SARS in the People’s Republic of 
China: an ecologic study., Environ. 
Health. 2 (2003) 15. https://doi.
org/10.1186/1476-069X-2-15.
[65] F. Nappi, L. Barrea, C. Di Somma, 
M.C. Savanelli, G. Muscogiuri, F. Orio, 
S. Savastano, Endocrine Aspects of 
Environmental “Obesogen” Pollutants., 
Int. J. Environ. Res. Public Health. 
13 (2016). https://doi.org/10.3390/
ijerph13080765.
[66] J.S. Kim, Z. Chen, T.L. Alderete, C. 
Toledo-Corral, F. Lurmann, K. Berhane, 
F.D. Gilliland, Associations of air 
pollution, obesity and cardiometabolic 
health in young adults: The Meta-
AIR study., Environ. Int. 133 (2019) 
105180. https://doi.org/10.1016/j.
envint.2019.105180.
[67] Z. Zheng, X. Xu, X. Zhang, A. 
Wang, C. Zhang, M. Hüttemann, L.I. 
Grossman, L.C. Chen, S. Rajagopalan, 
Q. Sun, K. Zhang, Exposure to ambient 
particulate matter induces a NASH-like 
phenotype and impairs hepatic glucose 
metabolism in an animal model., J. 
Hepatol. 58 (2013) 148-154. https://doi.
org/10.1016/j.jhep.2012.08.009.
[68] MD. Anway, A.S. Cupp, M. 
Uzumcu, M.K. Skinner, Epigenetic 
transgenerational actions of endocrine 
disruptors and male fertility., Science. 
308 (2005) 1466-1469. https://doi.
org/10.1126/science.1108190.
[69] R. Chamorro-García, M. Sahu, R.J. 
Abbey, J. Laude, N. Pham, B. Blumberg, 
Transgenerational inheritance of 
increased fat depot size, stem cell 
reprogramming, and hepatic steatosis 
elicited by prenatal exposure to the 
obesogen tributyltin in mice., Environ. 
Health Perspect. 121 (2013) 359-366. 
https://doi.org/10.1289/ehp.1205701.
[70] M. Manikkam, R. Tracey, C. 
Guerrero-Bosagna, M.K. Skinner, Plastics 
derived endocrine disruptors (BPA, 
DEHP and DBP) induce epigenetic 
transgenerational inheritance of 
obesity, reproductive disease and sperm 
epimutations., PLoS One. 8 (2013) 
e55387. https://doi.org/10.1371/journal.
pone.0055387.
[71] M. Manikkam, M.M. Haque, 
C. Guerrero-Bosagna, E.E. Nilsson, 
M.K. Skinner, Pesticide methoxychlor 
promotes the epigenetic transgenerational 
inheritance of adult-onset disease 
through the female germline., PLoS One. 
9 (2014) e102091. https://doi.org/10.1371/
journal.pone.0102091.
[72] R. Tracey, M. Manikkam, C. 
Guerrero-Bosagna, M.K. Skinner, 
Hydrocarbons (jet fuel JP-8) induce 
epigenetic transgenerational inheritance 
19
Environmental Obesogens and Human Health
DOI: http://dx.doi.org/10.5772/intechopen.96730
of obesity, reproductive disease 
and sperm epimutations., Reprod. 
Toxicol. 36 (2013) 104-116. https://doi.
org/10.1016/j.reprotox.2012.11.011.
[73] M.K. Skinner, M. Manikkam, 
R. Tracey, C. Guerrero-Bosagna, 
M. Haque, E.E. Nilsson, Ancestral 
dichlorodiphenyltrichloroethane 
(DDT) exposure promotes epigenetic 
transgenerational inheritance of obesity, 
BMC Med. 11 (2013) 228. https://doi.
org/10.1186/1741-7015-11-228.
[74] E. Whitelaw, Disputing Lamarckian 
epigenetic inheritance in mammals., 
Genome Biol. 16 (2015) 60. https://doi.
org/10.1186/s13059-015-0626-0.
[75] A.P. Starling, J.L. Adgate, R.F. 
Hamman, K. Kechris, A.M. Calafat, D. 
Dabelea, Prenatal exposure to per- and 
polyfluoroalkyl substances and infant 
growth and adiposity: the Healthy 
Start Study., Environ. Int. 131 (2019) 
104983. https://doi.org/10.1016/j.
envint.2019.104983.
[76] TI. Halldorsson, D. Rytter, L.S. 
Haug, B.H. Bech, I. Danielsen, G. 
Becher, T.B. Henriksen, S.F. Olsen, 
Prenatal exposure to perfluorooctanoate 
and risk of overweight at 20 years of age: 
a prospective cohort study., Environ. 
Health Perspect. 120 (2012) 668-673. 
https://doi.org/10.1289/ehp.1104034.
[77] J.M. Braun, A. Chen, ME Romano, 
A.M. Calafat, G.M. Webster, K. Yolton, 
B.P. Lanphear, Prenatal perfluoroalkyl 
substance exposure and child adiposity at 
8 years of age: The HOME study., Obesity 
(Silver Spring). 24 (2016) 231-237. 
https://doi.org/10.1002/oby.21258.
[78] T.J. Hartman, A.M. Calafat, A.K. 
Holmes, M. Marcus, K. Northstone, 
W.D. Flanders, K. Kato, E. V Taylor, 
Prenatal Exposure to Perfluoroalkyl 
Substances and Body Fatness in Girls., 
Child. Obes. 13 (2017) 222-230. https://
doi.org/10.1089/chi.2016.0126.
[79] A.M. Mora, E. Oken, S.L. Rifas-
Shiman, T.F. Webster, M.W. Gillman, 
A.M. Calafat, X. Ye, S.K. Sagiv, 
Prenatal Exposure to Perfluoroalkyl 
Substances and Adiposity in Early 
and Mid-Childhood., Environ. Health 
Perspect. 125 (2017) 467-473. https://doi.
org/10.1289/EHP246.
[80] P. Liu, F. Yang, Y. Wang, Z. Yuan, 
Perfluorooctanoic Acid (PFOA) 
Exposure in Early Life Increases Risk of 
Childhood Adiposity: A Meta-Analysis 
of Prospective Cohort Studies., Int. J. 
Environ. Res. Public Health. 15 (2018). 
https://doi.org/10.3390/ijerph15102070.
[81] J.P. Buckley, S.M. Engel, J.M. 
Braun, R.M. Whyatt, J.L. Daniels, M.A. 
Mendez, D.B. Richardson, Y. Xu, A.M. 
Calafat, M.S. Wolff, B.P. Lanphear, 
A.H. Herring, A.G. Rundle, Prenatal 
Phthalate Exposures and Body Mass 
Index Among 4- to 7-Year-old Children: 
A Pooled Analysis., Epidemiology. 27 
(2016) 449-458. https://doi.org/10.1097/
EDE.0000000000000436.
[82] D. Valvi, M. Casas, M.A. Mendez, 
A. Ballesteros-Gómez, N. Luque, S. 
Rubio, J. Sunyer, M. Vrijheid, Prenatal 
bisphenol a urine concentrations and 
early rapid growth and overweight 
risk in the offspring., Epidemiology. 24 
(2013) 791-799. https://doi.org/10.1097/
EDE.0b013e3182a67822.
[83] L.G. Kahn, C. Philippat, S.F. 
Nakayama, R. Slama, L. Trasande, 
Endocrine-disrupting chemicals: 
implications for human health., 
Lancet. Diabetes Endocrinol. 8 (2020) 
703-718. https://doi.org/10.1016/
S2213-8587(20)30129-7.
[84] B.E. Blake, S.M. Pinney, E.P. 
Hines, S.E. Fenton, K.K. Ferguson, 
Associations between longitudinal 
serum perfluoroalkyl substance 
(PFAS) levels and measures of thyroid 
hormone, kidney function, and body 
mass index in the Fernald Community 





[85] G. Liu, K. Dhana, J.D. Furtado, J. 
Rood, G. Zong, L. Liang, L. Qi, G.A. 
Bray, L. DeJonge, B. Coull, P. Grandjean, 
Q. Sun, Perfluoroalkyl substances and 
changes in body weight and resting 
metabolic rate in response to weight-
loss diets: A prospective study., PLoS 
Med. 15 (2018) e1002502. https://doi.
org/10.1371/journal.pmed.1002502.
[86] M. V Díaz Santana, S.E. Hankinson, 
C. Bigelow, S.R. Sturgeon, R.T. Zoeller, 
L. Tinker, J.A.E. Manson, A.M. 
Calafat, J.R. Meliker, K.W. Reeves, 
Urinary concentrations of phthalate 
biomarkers and weight change among 
postmenopausal women: a prospective 
cohort study., Environ. Health. 18 
(2019) 20. https://doi.org/10.1186/
s12940-019-0458-6.
[87] A. Pereira-Fernandes, C. Vanparys, 
T.L.M. Hectors, L. Vergauwen, D. 
Knapen, P.G. Jorens, R. Blust, Unraveling 
the mode of action of an obesogen: 
mechanistic analysis of the model 
obesogen tributyltin in the 3T3-L1 
cell line., Mol. Cell. Endocrinol. 370 
(2013) 52-64. https://doi.org/10.1016/j.
mce.2013.02.011.
[88] F. Ariemma, V. D’Esposito, D. 
Liguoro, F. Oriente, S. Cabaro, A. Liotti, 
I. Cimmino, M. Longo, F. Beguinot, 
P. Formisano, R. Valentino, Low-Dose 
Bisphenol-A Impairs Adipogenesis 
and Generates Dysfunctional 3T3-L1 
Adipocytes., PLoS One. 11 (2016) 
e0150762. https://doi.org/10.1371/
journal.pone.0150762.
[89] M.Á. Martínez, J. Blanco, J. Rovira, V. 
Kumar, J.L. Domingo, M. Schuhmacher, 
Bisphenol A analogues (BPS and BPF) 
present a greater obesogenic capacity in 
3T3-L1 cell line., Food Chem. Toxicol. an 
Int. J. Publ. Br. Ind. Biol. Res. Assoc. 140 
(2020) 111298. https://doi.org/10.1016/j.
fct.2020.111298.
[90] J.E. Davis, D. Hastings, Trans-
criptional Regulation of TCF/LEF and 
PPARγ by Daidzein and Genistein in 
3T3-L1 Preadipocytes., J. Med. Food. 21 
(2018) 761-768. https://doi.org/10.1089/
jmf.2017.0136.
[91] W. Qi, Q. Xu, Y. Xu, Z. Wang, L. 
Yang, S. Guo, Y. Shi, T. Zhao, L. Zhou, 
L. Ye, Effect of Notch pathway on lipid 
accumulation induced by mono-2-
ethylhexyl phthalate on 3T3-L1 cells., 
Ecotoxicol. Environ. Saf. 208 (2021) 
111472. https://doi.org/10.1016/j.
ecoenv.2020.111472.
[92] H. Masuno, S. Okamoto, J. Iwanami, 
K. Honda, T. Shiosaka, T. Kidani, K. 
Sakayama, H. Yamamoto, Effect of 
4-nonylphenol on cell proliferation and 
adipocyte formation in cultures of fully 
differentiated 3T3-L1 cells., Toxicol. 
Sci. 75 (2003) 314-320. https://doi.
org/10.1093/toxsci/kfg203.
[93] C.H. Hurst, D.J. Waxman, Activation 
of PPARalpha and PPARgamma by 
environmental phthalate monoesters., 
Toxicol. Sci. 74 (2003) 297-308. https://
doi.org/10.1093/toxsci/kfg145.
[94] A.M. Temkin, R.R. Bowers, M.E. 
Magaletta, S. Holshouser, A. Maggi, P. 
Ciana, L.J. Guillette, J.A. Bowden, J.R. 
Kucklick, J.E. Baatz, DD. Spyropoulos, 
Effects of Crude Oil/Dispersant 
Mixture and Dispersant Components 
on PPARγ Activity in Vitro and in 
Vivo: Identification of Dioctyl Sodium 
Sulfosuccinate (DOSS; CAS #577-11-
7) as a Probable Obesogen., Environ. 
Health Perspect. 124 (2016) 112-119. 
https://doi.org/10.1289/ehp.1409672.
[95] Z. Sun, H. Cao, Q.S. Liu, Y. 
Liang, H. Fiedler, J. Zhang, Q. Zhou, 
G. Jiang, 4-Hexylphenol influences 
adipogenic differentiation and hepatic 
lipid accumulation in vitro., Environ. 
Pollut. 268 (2021) 115635. https://doi.
org/10.1016/j.envpol.2020.115635.
[96] J.K. Hartman, T. Beames, B. Parks, 
D. Doheny, G. Song, A. Efremenko, 
21
Environmental Obesogens and Human Health
DOI: http://dx.doi.org/10.5772/intechopen.96730
M. Yoon, B. Foley, C. Deisenroth, 
P.D. McMullen, R.A. Clewell, An 
in vitro approach for prioritization 
and evaluation of chemical effects 
on glucocorticoid receptor mediated 
adipogenesis., Toxicol. Appl. Pharmacol. 
355 (2018) 112-126. https://doi.
org/10.1016/j.taap.2018.05.016.
[97] L. Ivry Del Moral, L. Le Corre, 
H. Poirier, I. Niot, T. Truntzer, J.-F. 
Merlin, P. Rouimi, P. Besnard, R. 
Rahmani, M.C. Chagnon, Obesogen 
effects after perinatal exposure of 
4,4′-sulfonyldiphenol (Bisphenol S) 
in C57BL/6 mice., Toxicology. 357-358 
(2016) 11-20. https://doi.org/10.1016/j.
tox.2016.05.023.
[98] R.Y. Wang, R.D. Abbott, A. 
Zieba, F.E. Borowsky, D.L. Kaplan, 
Development of a Three-Dimensional 
Adipose Tissue Model for Studying 
Embryonic Exposures to Obesogenic 
Chemicals., Ann. Biomed. Eng. 
45 (2017) 1807-1818. https://doi.
org/10.1007/s10439-016-1752-x.
[99] A. Brulport, D. Vaiman, M.-C. 
Chagnon, L. Le Corre, Obesogen effect 
of bisphenol S alters mRNA expression 
and DNA methylation profiling in 
male mouse liver., Chemosphere. 241 
(2020) 125092. https://doi.org/10.1016/j.
chemosphere.2019.125092.
[100] J. Watt, J.J. Schlezinger, Structurally-
diverse, PPARγ-activating environmental 
toxicants induce adipogenesis 
and suppress osteogenesis in bone 
marrow mesenchymal stromal cells., 
Toxicology. 331 (2015) 66-77. https://doi.
org/10.1016/j.tox.2015.03.006.
[101] Y. Yang, F. Sun, H. Chen, H. Tan, L. 
Yang, L. Zhang, J. Xie, J. Sun, X. Huang, 
Y. Huang, Postnatal exposure to DINP 
was associated with greater alterations 
of lipidomic markers for hepatic 
steatosis than DEHP in postweaning 
mice., Sci. Total Environ. 758 (2021) 
143631. https://doi.org/10.1016/j.
scitotenv.2020.143631.
[102] T.O. Owuor, M. Reid, L. Reschke, 
I. Hagemann, S. Greco, Z. Modi, K.H. 
Moley, Maternal obesogenic diet induces 
endometrial hyperplasia, an early 
hallmark of endometrial cancer, in a 
diethylstilbestrol mouse model., PLoS 
One. 13 (2018) e0186390. https://doi.
org/10.1371/journal.pone.0186390.
[103] J.F.P. de Araújo, P.L. Podratz, G.C. 
Sena, E. Merlo, L.C. Freitas-Lima, 
J.G.M. Ayub, A.F.Z. Pereira, A.P. Santos-
Silva, L. Miranda-Alves, I. V Silva, 
J.B. Graceli, The obesogen tributyltin 
induces abnormal ovarian adipogenesis 
in adult female rats., Toxicol. Lett. 295 
(2018) 99-114. https://doi.org/10.1016/j.
toxlet.2018.06.1068.
[104] A. Lyssimachou, J.G. Santos, A. 
André, J. Soares, D. Lima, L. Guimarães, 
C.M.R. Almeida, C. Teixeira, L.F.C. 
Castro, M.M. Santos, The Mammalian 
“Obesogen” Tributyltin Targets Hepatic 
Triglyceride Accumulation and the 
Transcriptional Regulation of Lipid 
Metabolism in the Liver and Brain 
of Zebrafish., PLoS One. 10 (2015) 
e0143911. https://doi.org/10.1371/journal.
pone.0143911.
[105] Z. Yu, J. Shen, Z. Li, J. Yao, W. 
Li, L. Xue, L.N. Vandenberg, D. Yin, 
Obesogenic Effect of Sulfamethoxazole 
on Drosophila melanogaster with 
Simultaneous Disturbances on Eclosion 
Rhythm, Glucolipid Metabolism, and 
Microbiota., Environ. Sci. Technol. 
54 (2020) 5667-5675. https://doi.
org/10.1021/acs.est.9b07889.
